Keywords: Pfizer, Lyrica, Patent, Teva Pharma

US Court confirms Pfizer patents on Lyrica valid through 2018

Article | 23 July 2012

Print This

The US District Court for the District of Delaware upheld the Pfizer (NYSE: PFE) composition of matter patent and pain ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in